Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-14

Clinical Trial Update: Perampanel in Focal Status Epilepticus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of perampanel for focal status epilepticus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perampanel (perampanel)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Epilepticus; Status, Focal Motor | Phase 3 | Status: TERMINATED